Takeda Reports FY2017 Full Year Results and Issues FY2018 Guidance

OSAKA, Japan–(BUSINESS WIRE)–May 14, 2018–Takeda Pharmaceutical Company Limited (TOKYO:4502): Underlying Revenue growth +5.5% led by Takeda’s Growth Drivers Underlying Revenue grew +5.5%, with Takeda’s Growth Drivers (Gastroenterology, Oncology …
( read original story …)


Related Post

Japan Post Bank targets more alternative investmen...
views 96
Japan Post Bank Co. Ltd (JPB), the banking unit of...
BREAKING NEWS: Japan is rattled by powerful 6.3-ma...
views 268
Japan has been rattle by a powerful 6.3-magnitude ...
Japan Bank Finances Danish Shipper
views 272
The Japan Bank for International Cooperation (JBIC...
Best Western Hotels expands in Osaka
views 210
“We look forward to welcoming the first guests to ...
Japan Airlines to add flights to Australia, Hawaii
views 285
TOKYO -- Japan Airlines will launch additional fli...
Tokyo: Stocks open higher
views 269
Tokyo stocks opened higher Tuesday, taking a posit...
Life could get choppy for Sea after $1 bln IPO
views 187
He declined to comment on the IPO. Throwing around...
Japan seen posting 41st straight current account s...
views 187
The finance ministry will release the data at 8:50...
15 years in, Mitsubishi Estate finds cash cow with...
views 274
... In the 15 years to the day Wednesday since Mit...
Hokkaido Barbarians to help Sapporo put best foot ...
views 86
Sapporo, which will host two games in next year's ...